R&D
More than 800 applied research projects
More than 30 years of research
More than 390 publications
Welcome to ROXALL's Research and Development Department, where innovation drives our mission to advance allergen immunotherapy.
Our team excels at optimizing and creating new allergen extracts, producing highly purified proteins for greater product consistency, and developing self-sufficient sources of raw materials such as insect venoms, house dust mites and animal dander. Through these efforts, we guarantee the highest quality and reliability in our immunotherapy products.
Our team excels at optimizing and creating new allergen extracts, producing highly purified proteins for greater product consistency, and developing self-sufficient sources of raw materials such as insect venoms, house dust mites and animal dander. Through these efforts, we guarantee the highest quality and reliability in our immunotherapy products.
RAW MATERIALS
Production of purified allergenic extracts from natural sources and our own cultures using processes that guarantee high quality standards.
ANIMAL EPITHELIA
ANIMAL EPITHELIA
Obtaining Felis domesticus (cat) and Canis familiaris (dog) allergenic extracts from the hair of both species.
MITES
MITES
Controlled production of allergenic extracts of different mite species from in-house cultures.
VENOMS
VENOMS
Extracting venom sacs from Hymenoptera and obtaining purified venoms.
FUNGI
FUNGI
Proprietary cultures of Alternaria alternata and other fungi of allergenic interest and purification of their main components.
PURIFIED PROTEINS
Purification of proteins of great importance in allergenic extracts.
Profilin
LTP
Fel d 1
Alt a 1
Cup a 1
BIOTECH
We are constantly working on other avenues of research.
Research into monoclonal antibodies for the detection of relevant allergens
Purification of natural and recombinant proteins for in vitro use